Status:
COMPLETED
To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions
Lead Sponsor:
Sandoz
Conditions:
Healthy
Eligibility:
All Genders
20-54 years
Phase:
PHASE1
Brief Summary
To demonstrate the relative bioavailability of Cefzil 500 mg Cefprozil tablets under fasting conditions.
Eligibility Criteria
Inclusion
- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
Exclusion
- Positive test results for HIV or hepatitis B or C.
- Treatment for drug or alcohol dependence.
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2004
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00881426
Start Date
March 1 2004
End Date
April 1 2004
Last Update
March 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.